Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HES Patch vs Blood Patch in Intracranial Hypotension
NCT02570724Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Jun 2013
- Primary completion
- Aug 2018
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of hetastarch in Intracranial hypotension (SIH) and post-dural puncture headache (PDPH) (2 arms), sponsored by Strasbourg University Hospital. Primary endpoint: Variation of the pulsatility index (PI) of the middle cerebral artery at 36 hours. Started Jun 2013; status: completed.
02
Drugs
hetastarch
03
Conditions
Intracranial hypotension (SIH)post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT02570724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02570724.